HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 208 filers reported holding HAEMONETICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $322,000 | -22.6% | 2,800 | -15.2% | 0.02% | -30.3% |
| Q3 2019 | $416,000 | +4.8% | 3,300 | 0.0% | 0.03% | +6.5% |
| Q2 2019 | $397,000 | +37.4% | 3,300 | 0.0% | 0.03% | +34.8% |
| Q1 2019 | $289,000 | -12.4% | 3,300 | 0.0% | 0.02% | -25.8% |
| Q4 2018 | $330,000 | -12.7% | 3,300 | 0.0% | 0.03% | +3.3% |
| Q3 2018 | $378,000 | +27.7% | 3,300 | 0.0% | 0.03% | +20.0% |
| Q2 2018 | $296,000 | +15.6% | 3,300 | -5.7% | 0.02% | +8.7% |
| Q1 2018 | $256,000 | +15.8% | 3,500 | -7.9% | 0.02% | +15.0% |
| Q4 2017 | $221,000 | -53.3% | 3,800 | -64.0% | 0.02% | -57.4% |
| Q3 2017 | $473,000 | -47.9% | 10,550 | -54.1% | 0.05% | -48.9% |
| Q2 2017 | $907,000 | -33.6% | 22,960 | -31.8% | 0.09% | -36.1% |
| Q1 2017 | $1,365,000 | -68.2% | 33,645 | -68.5% | 0.14% | -69.6% |
| Q4 2016 | $4,295,000 | -41.9% | 106,840 | -47.7% | 0.47% | -43.3% |
| Q3 2016 | $7,396,000 | +15.4% | 204,260 | -7.6% | 0.83% | +11.6% |
| Q2 2016 | $6,408,000 | -11.7% | 221,050 | +6.6% | 0.75% | -12.0% |
| Q1 2016 | $7,257,000 | +10.2% | 207,450 | +1.6% | 0.85% | +7.3% |
| Q4 2015 | $6,586,000 | -4.8% | 204,280 | -4.6% | 0.79% | -8.2% |
| Q3 2015 | $6,917,000 | -13.3% | 214,031 | +11.0% | 0.86% | -4.9% |
| Q2 2015 | $7,977,000 | -5.1% | 192,871 | +3.1% | 0.91% | -4.8% |
| Q1 2015 | $8,402,000 | +20.0% | 187,041 | -0.1% | 0.95% | +18.9% |
| Q4 2014 | $7,004,000 | +9.3% | 187,171 | +2.0% | 0.80% | +4.8% |
| Q3 2014 | $6,407,000 | +7.3% | 183,466 | +8.4% | 0.76% | +9.8% |
| Q2 2014 | $5,970,000 | +16.2% | 169,211 | +7.3% | 0.70% | +13.2% |
| Q1 2014 | $5,137,000 | +21.9% | 157,640 | +57.6% | 0.62% | +20.6% |
| Q4 2013 | $4,214,000 | +25.9% | 100,030 | +19.2% | 0.51% | +16.7% |
| Q3 2013 | $3,347,000 | +49.0% | 83,930 | +54.5% | 0.44% | +39.2% |
| Q2 2013 | $2,247,000 | – | 54,330 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |